{"transactions":[{"id":2620163,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":136764,"kind":"person","name":"Caffo Nathan","position":1,"cik":"0001816992","reported_name":"Caffo Nathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2021-08-02T20:02:54.000Z","date":"2021-07-29","kind":"purchase","acquired":true,"shares":6000,"price":8,"value":48000.0,"ownership":{"direct":true},"balance_after":6000,"source":{"system":"sec-edgar","filing":"0000899243-21-031086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816992/000089924321031086/doc4.xml","form_type":"4"}},{"id":3078963,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":136764,"kind":"person","name":"Caffo Nathan","position":1,"cik":"0001816992","reported_name":"Caffo Nathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Series B Convertible Preferred Stock","published_at":"2020-07-21T19:56:39.000Z","date":"2020-07-21","kind":"exercise","acquired":false,"shares":10529,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the reporting person's spouse."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10529},"source":{"system":"sec-edgar","filing":"0000899243-20-019906","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816992/000089924320019906/doc4.xml","form_type":"4"}},{"id":3078962,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":136764,"kind":"person","name":"Caffo Nathan","position":1,"cik":"0001816992","reported_name":"Caffo Nathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-07-21T19:56:39.000Z","date":"2020-07-21","kind":"exercise","acquired":true,"shares":10529,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 725 shares of Common Stock issued as payment of accrued dividends upon conversion of the preferred stock on July 21, 2020."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by the reporting person's spouse."}],"balance_after":11254,"source":{"system":"sec-edgar","filing":"0000899243-20-019906","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816992/000089924320019906/doc4.xml","form_type":"4"}},{"id":3080679,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":136764,"kind":"person","name":"Caffo Nathan","position":1,"cik":"0001816992","reported_name":"Caffo Nathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-07-17T19:01:25.000Z","date":"2020-07-16","kind":"grant","acquired":true,"shares":22794,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on August 16, 2020."}],"balance_after":22794,"derivative":{"exercise_price":19,"expiration_date":"2030-07-16","underlying":"Common Stock","underlying_shares":22794},"source":{"system":"sec-edgar","filing":"0000899243-20-019573","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816992/000089924320019573/doc4.xml","form_type":"4"}}]}